PIK3CA c.1388G>A ;(p.G463E)

Variant ID: 3-178928110-G-A

NM_006218.2(PIK3CA):c.1388G>A;(p.G463E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer.

British Journal Of Cancer
Nakayama, N N; Nakayama, K K; Yeasmin, S S; Ishibashi, M M; Katagiri, A A; Iida, K K; Fukumoto, M M; Miyazaki, K K
Publication Date: 2008-12-16

Variant appearance in text: PI3K: G463E
PubMed Link: 19018267
Variant Present in the following documents:
  • Main text
  • 6604783a.pdf
View BVdb publication page